Dialogic Medication Therapy Safety

Is there such a thing? Dialogical medication therapy safety?

On a Friday afternoon in March 2025, I stumble upon a LinkedIn post from a pharmacist. It captures my attention because several experts from my network have already commented on it. The pharmacist describes a case where she advised a patient against taking two medications simultaneously. However, the patient had received feedback from two doctors saying that the combination was fine.

I wonder: Did the patient actually speak with both doctors? The simple confirmation seems superficial. Presumably, the patient did not fulfill her responsibility and avoided direct confrontation.

How should professionals proceed in such situations? The lack of dialogue between pharmacy, general practitioner, and specialist is concerning. Often, rigid processes and responsibilities, as well as personal sensitivities, hinder constructive collaboration.

In my view, we must not blindly rely on care pathways or digital tools like the electronic patient record (ePA). This individual case demonstrates it. Until the ePA offers a reliable medication therapy safety check, direct communication between all parties involved remains essential – especially when it comes to life and death.